Our lab covers a broad spectrum of biomedical cancer research, from cellular mechanisms to clinical applications. Using a wide variety of invasion assays – from multifluidics to in vivo longitudinal imaging – we aim at generating novel knowledge on how digestive cancers metastatize. In parallel, our lab harnesses the organoid technology revolution – an innovative approach to model cancers ex vivo – to develop personalized medicine programs for colorectal and pancreatic cancers patients.